Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV 1 Infection”

2,210 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,210 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Early research (Phase 1)WithdrawnNCT06533280
What this trial is testing

VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

Who this might be right for
HIV Infections
ViiV Healthcare
Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Not applicableStudy completedNCT00026676
What this trial is testing

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 82
Not applicableUnknownNCT05071378
What this trial is testing

Leveraging Family-Based Assets for Black MSM In House Ball Communities

Who this might be right for
HIV I Infection
State University of New York - Downstate Medical Center 168
Not applicableLooking for participantsNCT04160455
What this trial is testing

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Who this might be right for
AutophagyGalectinsHIV Infections+1 more
Centre Hospitalier Régional d'Orléans 180
Testing effectiveness (Phase 2)Study completedNCT00074997
What this trial is testing

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

Who this might be right for
HIV-1
Janssen-Cilag Pty Ltd 1
Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing

Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Ended earlyNCT03493568
What this trial is testing

Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)

Who this might be right for
HIV-1-infection
IRCCS San Raffaele 100
Not applicableStudy completedNCT04621760
What this trial is testing

The OPENS Trial: Offering Women PrEP (Aim 1)

Who this might be right for
Human Immunodeficiency Virus TransmissionSexually Transmitted Diseases
University of California, San Francisco 189
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Testing effectiveness (Phase 2)Study completedNCT00398125
What this trial is testing

Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV-1 Infection
GlaxoSmithKline 30
Not applicableLooking for participantsNCT07293559
What this trial is testing

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

Who this might be right for
HIV-1-infectionBreastfeedingPregnancy Related
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1,150
Not applicableStudy completedNCT05294159
What this trial is testing

Implementing Long-Acting Novel Antiretrovirals

Who this might be right for
Human Immunodeficiency Viruses
Queen Mary University of London 114
Post-approval studies (Phase 4)Study completedNCT00466180
What this trial is testing

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University Hospital, Caen 62
Not applicableStudy completedNCT05044286
What this trial is testing

Longer-Acting PrEP in Transgender and Gender Diverse Texans

Who this might be right for
HIV-1-infection
University of Texas at Austin 565
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Testing effectiveness (Phase 2)Study completedNCT02738502
What this trial is testing

Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors

Who this might be right for
Maternal-fetal Infection Transmission
ANRS, Emerging Infectious Diseases 91
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Testing effectiveness (Phase 2)Study completedNCT00071097
What this trial is testing

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 330
Load More Results